Corteva (CTVA) Expected to Announce Quarterly Earnings on Tuesday

Corteva (NYSE:CTVA) is expected to be announcing its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect the company to announce earnings of ($0.49) per share and revenue of $2.4741 billion for the quarter. Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Wednesday, November 5, 2025 at 9:00 AM ET.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.89 by $0.31. The business had revenue of $6.46 billion during the quarter, compared to analyst estimates of $6.26 billion. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The firm’s revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.83 earnings per share. On average, analysts expect Corteva to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Corteva Price Performance

NYSE CTVA opened at $61.51 on Monday. The company has a 50 day simple moving average of $67.53 and a 200-day simple moving average of $69.40. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23. The firm has a market capitalization of $41.77 billion, a price-to-earnings ratio of 30.00, a price-to-earnings-growth ratio of 1.40 and a beta of 0.81. Corteva has a 52-week low of $53.40 and a 52-week high of $77.41.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, December 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Monday, December 1st. Corteva’s dividend payout ratio is 35.12%.

Insider Activity at Corteva

In other news, EVP Robert D. King sold 37,280 shares of Corteva stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $74.20, for a total value of $2,766,176.00. Following the transaction, the executive vice president owned 49,262 shares of the company’s stock, valued at $3,655,240.40. This trade represents a 43.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.15% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Brighton Jones LLC raised its position in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares during the last quarter. Nebula Research & Development LLC acquired a new position in shares of Corteva during the second quarter valued at about $1,290,000. Federated Hermes Inc. raised its position in shares of Corteva by 49.6% during the second quarter. Federated Hermes Inc. now owns 4,506 shares of the company’s stock valued at $336,000 after buying an additional 1,493 shares during the last quarter. Cresset Asset Management LLC raised its position in shares of Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after buying an additional 181 shares during the last quarter. Finally, Howland Capital Management LLC acquired a new stake in Corteva during the second quarter worth $300,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on CTVA shares. UBS Group reduced their price target on shares of Corteva from $85.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday. JPMorgan Chase & Co. raised shares of Corteva from a “neutral” rating to an “overweight” rating and set a $67.00 price target for the company in a research report on Thursday, October 2nd. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Wolfe Research cut their price objective on shares of Corteva from $80.00 to $79.00 and set an “outperform” rating on the stock in a research report on Monday, October 27th. Finally, Oppenheimer cut their price objective on shares of Corteva from $87.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 22nd. Fifteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus target price of $79.65.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.